FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004476106> ?p ?o ?g. }

• W2004476106 endingPage "711" @default.
• W2004476106 startingPage "706" @default.
• W2004476106 abstract "Objective. Anti-cyclic citrullinated peptide (anti-CCP) antibodies are strongly associated with increased risk of rheumatoid arthritis (RA).While the anti-CCP level is commonly dichotomized for clinical use, the best threshold for and utility of the titer as a continuous variable to predict development of RA are uncertain. Methods. Using data from the Nurses’ Health Study and Nurses’ Health Study II longitudinal cohorts, we examined the sensitivity, specificity, and hazard of RA at various thresholds of the anti-CCP. Incident RA was confirmed using the Connective Tissue Disease Screening Questionnaire and medical record review in 93 women from among 62,437 participants with blood samples. Three controls per case were randomly chosen, matching on cohort, age, and menopausal status. Stored plasma was tested for anti-CCP antibodies with the second-generation Diastat™ ELISA. Five threshold values were assessed for sensitivity, specificity, and time to diagnosis of RA. Hazard of RA was assessed with conditional logistic regression models adjusting for smoking and reproductive factors. Results. Using the suggested threshold of > 5 U/ml for anti-CCP positivity, specificity was 100%, but sensitivity was only 28%. A threshold of > 2 U/ml had a higher sensitivity (51%), and similar specificity (80%), with an odds ratio of 11.2 (95% confidence interval 4.7–26.9) for RA. Anti-CCP level as an ordinal variable was strongly associated with time to RA onset, with higher values predicting shorter time to RA onset. Conclusion. A lower threshold for anti-CCP positivity was more sensitive in predicting RA development. Higher ranges of the level were informative in predicting time to RA onset." @default.
• W2004476106 created "2016-06-24" @default.
• W2004476106 creator A5000782257 @default.
• W2004476106 creator A5014697619 @default.
• W2004476106 creator A5082819294 @default.
• W2004476106 creator A5086351530 @default.
• W2004476106 creator A5091621362 @default.
• W2004476106 date "2009-02-17" @default.
• W2004476106 modified "2023-10-16" @default.
• W2004476106 title "Comparison of Threshold Cutpoints and Continuous Measures of Anti-Cyclic Citrullinated Peptide Antibodies in Predicting Future Rheumatoid Arthritis" @default.
• W2004476106 cites W1831078481 @default.
• W2004476106 cites W1966438794 @default.
• W2004476106 cites W1990509922 @default.
• W2004476106 cites W2004304522 @default.
• W2004476106 cites W2013573826 @default.
• W2004476106 cites W2024988150 @default.
• W2004476106 cites W2036916905 @default.
• W2004476106 cites W2041560982 @default.
• W2004476106 cites W2053983530 @default.
• W2004476106 cites W2054343352 @default.
• W2004476106 cites W2063217417 @default.
• W2004476106 cites W2095138905 @default.
• W2004476106 cites W2104905749 @default.
• W2004476106 cites W2104935326 @default.
• W2004476106 cites W2107005433 @default.
• W2004476106 cites W2124313950 @default.
• W2004476106 cites W2127316198 @default.
• W2004476106 cites W2131987347 @default.
• W2004476106 cites W2136323238 @default.
• W2004476106 cites W2152348310 @default.
• W2004476106 cites W2160467744 @default.
• W2004476106 doi "https://doi.org/10.3899/jrheum.080895" @default.
• W2004476106 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3108039" @default.
• W2004476106 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19228654" @default.
• W2004476106 hasPublicationYear "2009" @default.
• W2004476106 type Work @default.
• W2004476106 sameAs 2004476106 @default.
• W2004476106 citedByCount "90" @default.
• W2004476106 countsByYear W20044761062012 @default.
• W2004476106 countsByYear W20044761062013 @default.
• W2004476106 countsByYear W20044761062014 @default.
• W2004476106 countsByYear W20044761062015 @default.
• W2004476106 countsByYear W20044761062016 @default.
• W2004476106 countsByYear W20044761062017 @default.
• W2004476106 countsByYear W20044761062018 @default.
• W2004476106 countsByYear W20044761062019 @default.
• W2004476106 countsByYear W20044761062020 @default.
• W2004476106 countsByYear W20044761062021 @default.
• W2004476106 countsByYear W20044761062022 @default.
• W2004476106 crossrefType "journal-article" @default.
• W2004476106 hasAuthorship W2004476106A5000782257 @default.
• W2004476106 hasAuthorship W2004476106A5014697619 @default.
• W2004476106 hasAuthorship W2004476106A5082819294 @default.
• W2004476106 hasAuthorship W2004476106A5086351530 @default.
• W2004476106 hasAuthorship W2004476106A5091621362 @default.
• W2004476106 hasBestOaLocation W20044761062 @default.
• W2004476106 hasConcept C126322002 @default.
• W2004476106 hasConcept C151956035 @default.
• W2004476106 hasConcept C156957248 @default.
• W2004476106 hasConcept C198451711 @default.
• W2004476106 hasConcept C203014093 @default.
• W2004476106 hasConcept C207103383 @default.
• W2004476106 hasConcept C2776232647 @default.
• W2004476106 hasConcept C2776670291 @default.
• W2004476106 hasConcept C2777077863 @default.
• W2004476106 hasConcept C2777575956 @default.
• W2004476106 hasConcept C2779075594 @default.
• W2004476106 hasConcept C2779134260 @default.
• W2004476106 hasConcept C44249647 @default.
• W2004476106 hasConcept C71924100 @default.
• W2004476106 hasConcept C72563966 @default.
• W2004476106 hasConceptScore W2004476106C126322002 @default.
• W2004476106 hasConceptScore W2004476106C151956035 @default.
• W2004476106 hasConceptScore W2004476106C156957248 @default.
• W2004476106 hasConceptScore W2004476106C198451711 @default.
• W2004476106 hasConceptScore W2004476106C203014093 @default.
• W2004476106 hasConceptScore W2004476106C207103383 @default.
• W2004476106 hasConceptScore W2004476106C2776232647 @default.
• W2004476106 hasConceptScore W2004476106C2776670291 @default.
• W2004476106 hasConceptScore W2004476106C2777077863 @default.
• W2004476106 hasConceptScore W2004476106C2777575956 @default.
• W2004476106 hasConceptScore W2004476106C2779075594 @default.
• W2004476106 hasConceptScore W2004476106C2779134260 @default.
• W2004476106 hasConceptScore W2004476106C44249647 @default.
• W2004476106 hasConceptScore W2004476106C71924100 @default.
• W2004476106 hasConceptScore W2004476106C72563966 @default.
• W2004476106 hasIssue "4" @default.
• W2004476106 hasLocation W20044761061 @default.
• W2004476106 hasLocation W20044761062 @default.
• W2004476106 hasLocation W20044761063 @default.
• W2004476106 hasLocation W20044761064 @default.
• W2004476106 hasOpenAccess W2004476106 @default.
• W2004476106 hasPrimaryLocation W20044761061 @default.
• W2004476106 hasRelatedWork W1981471379 @default.
• W2004476106 hasRelatedWork W2023721760 @default.
• W2004476106 hasRelatedWork W2037611947 @default.
• W2004476106 hasRelatedWork W2155117280 @default.
• W2004476106 hasRelatedWork W2335988042 @default.

• next